Federal grant programs / Department of Health and Human Services

The National Cardiovascular Health Program (93.426)

• Awarded, FY 2021 to 2025$278 million
• Grant awards123
• Typical award$1.2 million
• Awarded in FY 2025$0
• Size rank524 of 1,823
• Type of assistanceCooperative agreements

Key findings

• It is the 524th largest of 1,823 federal grant programs by five-year awards.
• The 20 largest recipients received 45% of the money.
• Awards went to recipients in 51 states and territories.

What the program funds

This program supports extensive scientific evidence, links nonmedical factors, including systemic racism and the lack of economic opportunities, with poor health outcomes and increased mortality rates, all of which are preventable. Factors such as poverty, inadequate housing, poor health care, and other debilitating social conditions, commonly referred to as social determinants of health, contribute to long-standing disparities and health inequities. These social conditions contribute to the increased prevalence of cardiovascular disease (CVD) in the US population. CVD is the leading cause of death in the US; stroke is the 5th leading cause. In 2020, about 1 in 5 adults who died from CVD were younger than 65 years old. It is estimated that 1 in 9 health care dollars are spent on CVD. CVD mortality rates declined for several decades due to both clinical and public health interventions, but recently declining death rates from both heart disease and stroke have stalled. One reason is that hypertension, the primary risk factor for CVD, is very common (1 in 2 US adults has hypertension) but control is not. Only 1 in 4 adults with hypertension (26.1%) has it under control. Gains have been made in treating high cholesterol, another primary risk factor for CVD. Overall, the age-adjusted prevalence of high cholesterol decreased from 21% to 10% from 1988–1994 to 2017–2018. This improvement is due in part to individuals’ healthy behaviors such as eating a healthy diet, losing weight, being physically active, and medication adherence, along with clinical contributions from appropriate prescribing and intensification of medication. Additional public health and health system interventions aimed at preventing, detecting, and controlling elevated cholesterol and blood pressure can help to further decrease CVD mortality.

From the federal Assistance Listing. Read the full listing on SAM.gov.

Open opportunities

No opportunity under this program is open or forecast on Grants.gov right now. Programs often post once a year, so the funding history below shows what to expect.

Rules from the program listing

Who can apply

State Governments or their Bona Fide Agents (includes the District of Columbia) are eligible

What the money can and cannot pay for

Funds for this program are to be used to implement and evaluate evidence-based strategies to address the challenges and systemic barriers that contribute to prevention and management of cardiovascular disease and diabetes in high-burden populations.

Matching requirements

This program has no statutory formula. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.

Deadlines

Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.

Award range and average, in the agency's words

Average award $1,000,000 Range $850,000 - $2,000,000

Quoted from the program's federal Assistance Listing. The notice of funding opportunity is the official source for each competition's rules.

Who usually wins

State and local governments received 96% of the money, nonprofits 1.3% and colleges and universities 1.2%.

By state

Each state below has its own page for this program, with its recipients and yearly totals.

Award amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.